Literature DB >> 12525697

Contribution of Fas to diabetes development.

Alexei Y Savinov1, Andrew Tcherepanov, E Allison Green, Richard A Flavell, Alexander V Chervonsky.   

Abstract

Fas (Tnfrsf6, Apo-1, CD95) is a death receptor involved in apoptosis induced in many cell types. Fas have been shown to be expressed by insulin-producing beta cells in mice and humans. However, the importance of Fas in the development of autoimmune diabetes remains controversial. To further evaluate the importance of Fas in pathogenesis of diabetes, we generated NOD mice (nonobese diabetic mice developing spontaneous autoimmune diabetes) with beta cell-specific expression of a dominant-negative point mutation in a death domain of Fas, known as lpr(cg) or Fas(cg). Spontaneous diabetes was significantly delayed in NOD mice expressing Fas(cg), and the effect depended on the expression level of the transgene. However, Fas(cg)-bearing mice were still sensitive to diabetes transferred by splenocytes from overtly diabetic NOD mice. At the same time, Fas(cg) expression did neutralize the accelerating effect of transgenic Fas-ligand expressed by the same beta cells. Thus, both Fas-dependent and -independent mechanisms are involved in beta cell destruction, but interference with the Fas pathway early in disease development may retard or prevent diabetes progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12525697      PMCID: PMC141047          DOI: 10.1073/pnas.0237359100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Staining pattern of the brush border and detection of cytoplasmic granules in the uriniferous tubules of female DBA/2Cr mouse kidney: comparison among various fixations and stains.

Authors:  A Yabuki; S Suzuki; M Matsumot; M Kurohmaru; Y Hayashi; H Nishinakagawa
Journal:  J Vet Med Sci       Date:  2001-12       Impact factor: 1.267

Review 2.  The role of CD4 vs. CD8 T cells in IDDM.

Authors:  F S Wong; C A Janeway
Journal:  J Autoimmun       Date:  1999-11       Impact factor: 7.094

3.  Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.

Authors:  S Kim; K A Kim; D Y Hwang; T H Lee; N Kayagaki; H Yagita; M S Lee
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

4.  IFN-gamma affects homing of diabetogenic T cells.

Authors:  A Y Savinov; F S Wong; A V Chervonsky
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

5.  IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.

Authors:  A Amrani; J Verdaguer; S Thiessen; S Bou; P Santamaria
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

Review 6.  A choice of death--the signal-transduction of immune-mediated beta-cell apoptosis.

Authors:  D L Eizirik; T Mandrup-Poulsen
Journal:  Diabetologia       Date:  2001-12       Impact factor: 10.122

7.  Proinflammatory consequences of transgenic fas ligand expression in the heart.

Authors:  D P Nelson; E Setser; D G Hall; S M Schwartz; T Hewitt; R Klevitsky; H Osinska; D Bellgrau; R C Duke; J Robbins
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

8.  Significant role for Fas in the pathogenesis of autoimmune diabetes.

Authors:  X Su; Q Hu; J M Kristan; C Costa; Y Shen; D Gero; L A Matis; Y Wang
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

9.  The membrane-bound but not the soluble form of human Fas ligand is responsible for its inflammatory activity.

Authors:  K Shudo; K Kinoshita; R Imamura; H Fan; K Hasumoto; M Tanaka; S Nagata; T Suda
Journal:  Eur J Immunol       Date:  2001-08       Impact factor: 5.532

10.  A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen.

Authors:  N Itoh; S Nagata
Journal:  J Biol Chem       Date:  1993-05-25       Impact factor: 5.157

View more
  25 in total

Review 1.  Viruses and cytotoxic T lymphocytes in type 1 diabetes.

Authors:  Ken T Coppieters; Matthias G von Herrath
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

Review 2.  The consequences of apoptosis in autoimmunity.

Authors:  Ana Lleo; Carlo Selmi; Pietro Invernizzi; Mauro Podda; M Eric Gershwin
Journal:  J Autoimmun       Date:  2008-06-02       Impact factor: 7.094

Review 3.  Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease.

Authors:  Kate L Graham; Robyn M Sutherland; Stuart I Mannering; Yuxing Zhao; Jonathan Chee; Balasubramanian Krishnamurthy; Helen E Thomas; Andrew M Lew; Thomas W H Kay
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development.

Authors:  Zuoxiang Xiao; Abdiaziz S Mohamood; Sophia Uddin; Rachel Gutfreund; Chiaki Nakata; Andrew Marshall; Hiroaki Kimura; Patrizio Caturegli; Karl L Womer; Yanfei Huang; Chunfa Jie; Shukti Chakravarti; Jonathan P Schneck; Hideo Yagita; Abdel Rahim A Hamad
Journal:  Am J Pathol       Date:  2011-06-15       Impact factor: 4.307

5.  In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18.

Authors:  Li Wen; Elizabeth A Green; Thomas Stratmann; Anaïs Panosa; Ramon Gomis; Elizabeth E Eynon; Richard A Flavell; Jovita A Mezquita; Conchi Mora
Journal:  Eur J Immunol       Date:  2011-04-13       Impact factor: 5.532

6.  Non-viral systemic delivery of Fas siRNA suppresses cyclophosphamide-induced diabetes in NOD mice.

Authors:  Ji Hoon Jeong; Sun Hwa Kim; Minhyung Lee; Won Jong Kim; Tae Gwan Park; Kyung Soo Ko; Sung Wan Kim
Journal:  J Control Release       Date:  2010-01-18       Impact factor: 9.776

7.  Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas.

Authors:  Irina Bonzheim; Eva Geissinger; Wen-Yu Chuang; Sabine Roth; Philipp Ströbel; Alexander Marx; Peter Reimer; Martin Wilhelm; Bernhard Puppe; Andreas Rosenwald; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  J Hematop       Date:  2008-04-24       Impact factor: 0.196

8.  Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes.

Authors:  V M de Jong; A R van der Slik; S Laban; R van 't Slot; B P C Koeleman; A Zaldumbide; B O Roep
Journal:  Genes Immun       Date:  2016-07-28       Impact factor: 2.676

Review 9.  Cellular FLICE-inhibitory protein: an attractive therapeutic target?

Authors:  Olivier Micheau
Journal:  Expert Opin Ther Targets       Date:  2003-08       Impact factor: 6.902

10.  Protection from autoimmune diabetes and T-cell lymphoproliferation induced by FasL mutation are differentially regulated and can be uncoupled pharmacologically.

Authors:  Abdiaziz S Mohamood; Mehmet L Guler; Zuoxiang Xiao; Dongfeng Zheng; Allan Hess; Yi Wang; Hideo Yagita; Jonathan P Schneck; Abdel Rahim A Hamad
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.